Clinically significant interactions with dutasteride are not known. However, the rate of undifferentiated prostate carcinoma was higher in the verum group without an effect on overall survival (Goodman et al., 2019). Furthermore, the function of 5α-reductase on other steroids is poorly understood. Part of the study was done at the Clinical Research Center, University of Washington and the General Clinical Research Center, Harbor-UCLA Medical Center. Marilyn Busher, Kathy Winter and Kathryn Torrez Duncan assisted with study clinical aspects. There were no signifi-cant differences in the testosterone levels or the change in testosterone levels after treatment between the two groups. When analysed by baseline serum testosterone tertile, the increases in serum testosterone level among the dutasteride and combination group were greatest in the lowest tertile. Scalp DHT concentrations in the Dutasteride groups were significantly suppressed compared with placebo in a dose-related manner. Depends on their sensitivity, as some men can’t even prevent hair loss with 0 DHT and their regular endogenous Testosterone levels. It never did, and Testosterone’s lack of anabolic selectivity in the body was revealed and quite obvious once you take into account that my facial hair, body hair and hair loss was nearly unaltered in contrast to what a slightly lower level of Testosterone in my body with DHT present would induce. I would have kept using Dutasteride if it worked the way I predicted it was going to work in 2017 before the experiment, but it didn't inhibit my systemic Testosterone at all from inducing androgenic activity at the hair follicle. Men who decide to transition from male to female will often be prescribed an oral anti-androgen and oral estrogen. One study I was looking at recently was a study following the progress of a man who had a serum Testosterone level of 455 ng/dL and had already experienced significant male pattern baldness throughout his lifetime R. Finasteride directly reduces prostate size by inhibiting DHT, which the majority of the population has acknowledged is also what prevents progression of hair loss. Androgenic alopecia never let up until I addressed androgens, and to be clear, for 90-99% of men, the same will apply. I've been on 500 milligrams of Test with Dianabol in the past (among other heavily aromatizing compounds) and had absurdly out of range Estrogen levels because I was young, stupid and wasn't using an aromatase inhibitor (AI) to manage my hormones correctly. I've kept in the middle just by not using those androgens, and manually managed it at other times when I was using those drugs. Conversely, following a single 5 mg dose of finasteride, mean peak levels of finasteride were 37 ng/mL (99 nmol/L), and plasma concentrations increased by 47–54% following 2.5 weeks of continued daily administration. In accordance with finasteride being a potent 5α-reductase inhibitor but a weak inhibitor of 5β-reductase, the medication decreases circulating levels of 5α-reduced steroids like allopregnanolone but does not reduce concentrations of 5β-reduced steroids like pregnanolone. By inhibiting 5α-reductase and thus preventing DHT production, finasteride reduces androgen signaling in tissues like the prostate gland and the scalp. This is in contrast to inhibitors of all three isoenzymes of 5α-reductase like dutasteride, which can reduce DHT levels in the entire body by more than 99%. In 2016 Merck was a defendant in approximately 1,370 product liability lawsuits which had been filed by customers alleging they had experienced persistent sexual side-effects following cessation of treatment with finasteride. In 2025, the European Medicines Agency confirmed that suicidal thoughts can occur as a side effect of the hair-loss treatment finasteride and similar dutasteride. Merck's patent on finasteride for the treatment of BPH expired in June 2006. Finasteride is marketed primarily under the brand names Propecia, for pattern hair loss, and Proscar, for BPH, both of which are products of Merck & Co. It was the first 5α-reductase inhibitor to be introduced and was followed by dutasteride in 2001. While some are effective and are worth exploring for certain individuals (more on that in future articles), the root of the issue still derives from androgens. This was actually one of the least impressive reversals I could reference, and the only reason I chose this one was because it is in PubMed and clearly states exactly what their hormone levels were before and after. At best, it has that two-to-one selectivity for muscle tissue to prostate, and many other studies indicate that a two-to-one ratio is extremely generous. This is typically assessed in preclinical animal models when analyzing the efficacy of possible hormone replacement therapy alternatives by comparing a drugs stimulation of muscle growth relative to the stimulation of prostate and seminal vesicles growth. If you reference the clinical data on Testosterone itself, you can clearly see that it stimulates prostate growth itself inherently, just to a lesser extent than DHT R. The first thing that I think needs to be taken into consideration that's largely overlooked is the fact that Finasteride and Dutasteride were created to address prostate size. Within groups, Kruskal-Wallis rank sum tests were used to assess dose relationships. Free testosterone and free DHT were calculated.34 Sex-hormone binding globulin and luteinizing hormone were measured using immunofluormetric assays with sensitivities of 2.5 nmol/L and 0.1 U/L, respectively.26,35 The interassay coefficient of variation for the testosterone assay was 7.7% at 241 ng/dL of testosterone, 4.4% at 532 ng/dL of testosterone, and 3.3% at 1016 ng/dL of testosterone. Testosterone and DHT were measured using liquid chromatography tandem mass spectrometry32,33 with sensitivities of 2 and 5 ng/dL, respectively. Strength was reassessed within 2 to 7 days; if the measurements were within 5%, the better of the 2 measurements was recorded.25,26 Sexual function was assessed using the International Index of Erectile Function.27 Additionally, we used the Male Sexual Health Questionnaire for a more comprehensive assessment of sexual desire28 than is provided by the International Index of Erectile Function. The primary outcome was change in fat-free mass from baseline measured by dual-energy x-ray absorptiometry. The FDA and EMA have published warnings regarding neuropsychiatric side effects of dutasteride. Long-term use of dutasteride can lead to serious side effects. Good oral absorption of dutasteride independent of meals, high plasma protein binding, hepatic elimination, excretion of metabolites via the faeces. In adult men, inhibition of 5α-reductase is used to treat benign prostatic hyperplasia and androgenetic alopecia. Dutasteride is a synthetic steroid similar to testosterone; it leads to a competitive inhibition of the 5α-reductase 1–3. Longer term studies are warranted to optimize the dose and determine the safety and efficacy of this approach to androgen replacement therapy.